Docusate Sodium Market Analysis and Global Forecast 2023-2033

$ 1,390.00$ 5,520.00

Docusate Sodium Market Research Report: Information By Type (DSS 100%, DSS 85%, DSS 50%), By Application (Exicipient, Active Pharmaceutical Ingredients) and By Region — Forecast till 2033

Report Published on: October 14, 2024
$ 3,470.00
$ 5,520.00
$ 1,390.00
Report Code: EBI75146 Categories: ,
Description

Docusate Sodium Market Overview

The global Docusate Sodium Market Size is expected to reach USD 21.51 Billion by 2033. The global Docusate Sodium industry size accounted for USD 13.95 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 4.42% from 2023 to 2033. Docusate sodium is a widely used medication that helps to relieve constipation and other digestive problems. It is often used to help patients who have undergone surgery, those who are bedridden or have limited mobility, and those who are on certain medications that can cause constipation as a side effect. Docusate sodium is also used in the treatment of certain medical conditions such as hemorrhoids and irritable bowel syndrome.

The global market for docusate sodium has been growing steadily in recent years due to the increasing prevalence of constipation and other digestive disorders, particularly among the older people population. According to the World Health Organization (WHO), the global population aged 60 and above is expected to reach 2 billion by 2050, more than triple the number in 2000. This aging population is driving the demand for drugs that can help manage age-related health issues such as constipation.

Global Docusate Sodium Market Synopsis

Global Docusate Sodium Market AnalysisCOVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the docusate sodium market. The outbreak of the virus has led to disruptions in the supply chain, causing shortages of raw materials and finished products. Furthermore, the lockdowns and travel restrictions imposed by governments worldwide have affected the production and distribution of docusate sodium, leading to delays in delivery and increased prices.

However, as the world gradually recovers from the pandemic, the demand for docusate sodium is expected to rise. The increase in the aging population, coupled with the growing incidence of constipation and other digestive disorders, will drive the demand for docusate sodium in the coming years.

Docusate Sodium Market Dynamics

The major factors that have impacted the growth of Docusate Sodium are as follows:

Drivers:

Growing Incidence of Digestive Disorders

One of the major driving factors of the docusate sodium market is the growing incidence of digestive disorders. Constipation is one of the most common digestive disorders, affecting millions of people worldwide. According to a study published in the American Journal of Gastroenterology, nearly 16% of adults suffer from constipation.

The increase in sedentary lifestyles, poor dietary habits, and stress levels have contributed to the rise in digestive disorders. As a result, there is a growing demand for medications such as docusate sodium to manage constipation and other digestive problems.

Restraint:

  • Side Effects of Docusate Sodium

While docusate sodium is generally considered safe, it may cause side effects in some people. The most common side effects include abdominal cramps, diarrhea, nausea, and vomiting. In rare cases, it may cause allergic reactions such as itching, swelling, and difficulty breathing.

The potential side effects of docusate sodium may discourage some people from using the medication, leading to a decline in demand. Furthermore, the availability of alternative treatments such as dietary changes, exercise, and other laxatives may also restrain the growth of the docusate sodium market.

Opportunity:

Rising Awareness about Digestive Health

The growing awareness about the importance of digestive health presents a significant opportunity for the docusate sodium market. People are becoming more conscious of the impact of poor dietary habits, stress, and sedentary lifestyles on their digestive health. As a result, there is a growing demand for products that can help manage digestive problems.

Moreover, the rise of e-commerce platforms and online pharmacies has made it easier for people to access medications such as docusate sodium. This trend is expected to continue, leading to increased sales and revenue for the docusate sodium market.

Docusate Sodium Segment Overview

By Type

Based on the Type, the market is segmented based on DSS 100%, DSS 85%, and DSS 50%. the DSS 100% segment holds the largest share in the market by type. This is due to the fact that DSS 100% is the purest form of docusate sodium and is the most effective in treating constipation. It is widely used in hospitals, clinics, and at home for both short-term and long-term treatment of constipation.

By Application

Docusate Sodium Market Application AnalysisBased on Application, the market has been divided into Exicipient, Active Pharmaceutical Ingredients. the excipient segment holds the largest share in the market. This is due to the fact that docusate sodium is widely used as an excipient in the pharmaceutical industry, as it helps to improve the solubility and bioavailability of drugs. Docusate sodium is also used as an excipient in the production of various other pharmaceutical products, including tablets, capsules, and suspensions.

Overall, the high demand for docusate sodium in the healthcare industry, particularly for the treatment of constipation, is driving the growth of the market. Additionally, the increasing use of docusate sodium as an excipient in the pharmaceutical industry is also contributing to the market’s growth.

Global Docusate Sodium Market Regional Analysis

Based on region, the global Logistics Intelligence Software market has been divided into North America, Europe, Asia-Pacific, South America and Middle East & Africa. North America is projected to dominate the use of the market followed by the Europe and Asia-Pacific regions.

Global Docusate Sodium Market Regional AnalysisNorth America Market

The docusate sodium market in North America is primarily driven by the increasing incidence of digestive disorders and a growing geriatric population. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an estimated 60 to 70 million people in the United States are affected by digestive diseases. Moreover, the aging population in North America is also contributing to the growth of the docusate sodium market as older adults are more prone to digestive problems. Additionally, the presence of key market players and advanced healthcare infrastructure are also driving the market growth in North America.

Europe Market

The docusate sodium market in Europe is also driven by the high prevalence of digestive disorders and the aging population. The European Society for Primary Care Gastroenterology (ESPCG) estimates that approximately 25% of the European population suffers from digestive disorders. Moreover, the increasing geriatric population in Europe is also contributing to the growth of the market as this demographic is more prone to constipation and other digestive problems. Additionally, the presence of advanced healthcare infrastructure and the availability of government-funded healthcare systems in countries such as Germany and France are also driving the market growth in Europe.

Competitive Landscape

The global docusate sodium market is highly competitive, with numerous players offering a wide range of software solutions. The competitive landscape is characterized by the presence of established companies, as well as emerging startups and niche players. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as product launches, and strategic alliances.

Prominent Players:

  • Cytec Industries
  • Laxachem
  • Aqualax
  • Calube
  • Colace
  • Docusol
  • Coloxyl
  • DulcoEase
  • Anofer Sun
  • Fe-King PN

Key Development:

August 2020: Amneal Pharmaceuticals LLC launched a new docusate sodium capsule under the brand name “Dulcolax Pink Stool Softener.” This product launch helped the company to expand its product portfolio and strengthen its position in the market.

Scope of the Report

Global Docusate Sodium Market, by Type

  • DSS 100%
  • DSS 85%
  • DSS 50%

Global Docusate Sodium Market, by Application

  • Exicipient
  • Active Pharmaceutical Ingredients

Global Docusate Sodium Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Benelux
    • Nordic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Indonesia
    • Austalia
    • Malaysia
    • India
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of Middle East & Africa

 

Parameters Indicators
Market Size 2033: $21.51 Billion
CAGR 4.42% CAGR (2023-2033)
Base year 2022
Forecast Period 2023-2033
Historical Data 2021
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Type, Application
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors Cytec Industries, Laxachem, Aqualax, Calube, Colace, Docusol, Coloxyl, DulcoEase, Anofer Sun, and Fe-King PN
Key Market Opportunities Rising Awareness about Digestive Health
Key Market Drivers Growing Incidence of Digestive Disorders

 

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Docusate Sodium market trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities in the future
  • Docusate Sodium market historical market size for the year 2021, and forecast from 2023 to 2033
  • Docusate Sodium market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, Active Pharmaceutical Ingredients strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
  • To identify and understand the various factors involved in the global Docusate Sodium market affected by the pandemic
  • To provide a detailed insight into the major companies operating in the market. The profiling will include the Active Pharmaceutical Ingredients health of the company’s past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

For more details mail us at

Ask a question / additional requirement

Frequently Asked Questions (FAQ)

The global Docusate Sodium market is growing at a CAGR of 4.42% over the next 10 years

Asia Pacific is expected to register the highest CAGR during 2023-2033

Cytec Industries, Laxachem, Aqualax, Calube, Colace, Docusol, Coloxyl, DulcoEase, Anofer Sun, and Fe-King PN are the major companies operating in the market.

Yes, we offer 16 hours of analyst support to solve the queries

Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

Table of Content

Table of Content

Chapter 1.   Executive Summary

Chapter 2.   Scope Of The Study

                     2.1.   Market Definition

                     2.2.   Scope Of The Study

                               2.2.1.   Objectives of Report

                               2.2.2.   Limitations

                     2.3.   Market Structure

Chapter 3.   Evolve BI Methodology

Chapter 4.   Market Insights and Trends

                     4.1.   Supply/ Value Chain Analysis

                               4.1.1.   Raw End Users Providers

                               4.1.2.   Manufacturing Process

                               4.1.3.   Distributors/Retailers

                               4.1.4.   End-Use Industry

                     4.2.   Porter’s Five Forces Analysis

                               4.2.1.   Threat Of New Entrants

                               4.2.2.   Bargaining Power Of Buyers

                               4.2.3.   Bargaining Power Of Suppliers

                               4.2.4.   Threat Of Substitutes

                               4.2.5.   Industry Rivalry

                     4.3.   Impact Of COVID-19 on the Docusate Sodium Market

                               4.3.1.   Impact on Market Size

                               4.3.2.   End-Use Industry Trend, Preferences, and Budget Impact

                               4.3.3.   Regulatory Framework/Government Policies

                               4.3.4.   Key Players' Strategy to Tackle Negative Impact

                               4.3.5.   Opportunity Window

                     4.4.   Technology Overview

                     4.5.   Macro factor

                     4.6.   Micro Factor

                        4.7.   Demand Supply Gap Analysis of the Docusate Sodium Market

                        4.8.   Import Analysis of the Docusate Sodium Market

                        4.9.   Export Analysis of the Docusate Sodium Market

Chapter 5.   Market Dynamics

                     5.1.   Introduction

                     5.2.   DROC Analysis

                               5.2.1.   Drivers

                               5.2.2.   Restraints

                               5.2.3.   Opportunities

                               5.2.4.   Challenges

                     5.3.   Patent Analysis

                     5.4.   Industry Roadmap

                     5.5.   Parent/Peer Market Analysis

Chapter 6.   Global Docusate Sodium Market, By Type

                     6.1.   Introduction

                     6.2.   DSS 100%

                     6.3.   DSS 85%

                     6.4   DSS 50%

                     6.5.   Prescriptive Analysis

Chapter 7.   Global Docusate Sodium Market, By Application

                     7.1.   Introduction

                     7.2.   Exicipient

                     7.3.   Active Pharmaceutical Ingredient

 

Chapter 8.   Global Docusate Sodium Market, By Region

                     8.1.   Introduction

                     8.2.   North America

                               8.2.1.   Introduction

                               8.2.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               8.2.3.   Market Size and Forecast, By Country, 2023-2033

                               8.2.4.   Market Size and Forecast, By Type, 2023-2033

                               8.2.5.   Market Size and Forecast, By Application, 2023-2033

                               8.2.6.   US

                                              8.2.6.1.   Introduction

                                              8.2.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.2.6.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.2.6.4.   Market Size and Forecast, By Application, 2023-2033

                               8.2.7.   Canada

                                              8.2.7.1.   Introduction

                                              8.2.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.2.7.4.   Market Size and Forecast, By Type, 2023-2033

                                              8.2.7.5.   Market Size and Forecast, By Application, 2023-2033

                     8.3.   Europe

                               8.3.1.   Introduction

                               8.3.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               8.3.3.   Market Size and Forecast, By Country, 2023-2033

                               8.3.4.   Market Size and Forecast, By Type, 2023-2033

                               8.3.5.   Market Size and Forecast, By Application, 2023-2033

                               8.3.6.   Germany

                                              8.3.6.1.   Introduction

                                              8.3.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.3.6.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.3.6.4.   Market Size and Forecast, By Application, 2023-2033

                               8.3.7.   France

                                              8.3.7.1.   Introduction

                                              8.3.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.3.7.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.3.7.4.   Market Size and Forecast, By Application, 2023-2033

                               8.3.8.   UK

                                              8.3.8.1.   Introduction

                                              8.3.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.3.8.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.3.8.4.   Market Size and Forecast, By Application, 2023-2033

                               8.3.9.   Italy

                                              8.3.9.1.   Introduction

                                              8.3.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.3.9.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.3.9.4.   Market Size and Forecast, By Application, 2023-2033

                               8.3.11.   Rest Of Europe

                                              8.3.11.1.   Introduction

                                              8.3.11.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.3.11.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.3.11.4.   Market Size and Forecast, By Application, 2023-2033

                     8.4.   Asia-Pacific

                               8.4.1.   Introduction

                               8.4.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               8.4.3.   Market Size and Forecast, By Country, 2023-2033

                               8.4.4.   Market Size and Forecast, By Type, 2023-2033

                               8.4.5.   Market Size and Forecast, By Application, 2023-2033

                               8.4.6.   China

                                              8.4.6.1.   Introduction

                                              8.4.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.4.6.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.4.6.4.   Market Size and Forecast, By Application, 2023-2033

                               8.4.7.   India

                                              8.4.7.1.   Introduction

                                              8.4.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.4.7.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.4.7.4.   Market Size and Forecast, By Application, 2023-2033

                               8.4.8.   Japan

                                              8.4.8.1.   Introduction

                                              8.4.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.4.8.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.4.8.4.   Market Size and Forecast, By Application, 2023-2033

                               8.4.9.   South Korea

                                              8.4.9.1.   Introduction

                                              8.4.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.4.9.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.4.9.4.   Market Size and Forecast, By Application, 2023-2033

                               8.4.10.   Rest Of Asia-Pacific

                                              8.4.10.1.   Introduction

                                              8.4.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                              8.4.10.3.   Market Size and Forecast, By Type, 2023-2033

                                              8.4.10.4.   Market Size and Forecast, By Application, 2023-2033

                     8.5.   Rest Of The World (RoW)

                               8.5.1.   Introduction

                               8.5.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                               8.5.3.   Market Size and Forecast, By Type, 2023-2033

                               8.5.4.   Market Size and Forecast, By Application, 2023-2033

Chapter 9.   Company Landscape

                     9.1.   Introduction

                     9.2.   Vendor Share Analysis

                     9.3.   Key Development Analysis

                     9.4.   Competitor Dashboard

Chapter 10.   Company Profiles

                     10.1.   Cytec Industries

                               10.1.1.   Business Overview

                               10.1.2.   Active Pharmaceutical Ingredients Analysis

                                              10.1.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.1.3.   Product Portfolio

                               10.1.4.   Recent Development and Strategies Adopted

                               10.1.5.   SWOT Analysis

                     10.2.   Laxachem

                               10.2.1.   Business Overview

                               10.2.2.   Active Pharmaceutical Ingredients Analysis

                                              10.2.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.2.3.   Product Portfolio

                               10.2.4.   Recent Development and Strategies Adopted

                               10.2.5.   SWOT Analysis

                     10.3.   Aqualax

                               10.3.1.   Business Overview

                               10.3.2.   Active Pharmaceutical Ingredients Analysis

                                              10.3.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.3.3.   Product Portfolio

                               10.3.4.   Recent Development and Strategies Adopted

                               10.3.5.   SWOT Analysis

                     10.4.   Calube

                               10.4.1.   Business Overview

                               10.4.2.   Active Pharmaceutical Ingredients Analysis

                                              10.4.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.4.3.   Product Portfolio

                               10.4.4.   Recent Development and Strategies Adopted

                               10.4.5.   SWOT Analysis

                     10.5.   Colace

                               10.5.1.   Business Overview

                               10.5.2.   Active Pharmaceutical Ingredients Analysis

                                              10.5.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.5.3.   Product Portfolio

                               10.5.4.   Recent Development and Strategies Adopted

                               10.5.5.   SWOT Analysis

                     10.6.   Docusol

                               10.6.1.   Business Overview

                               10.6.2.   Active Pharmaceutical Ingredients Analysis

                                              10.6.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.6.3.   Product Portfolio

                               10.6.4.   Recent Development and Strategies Adopted

                               10.6.5.   SWOT Analysis

                     10.7.   Coloxyl

                               10.7.1.   Business Overview

                               10.7.2.   Active Pharmaceutical Ingredients Analysis

                                              10.7.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.7.3.   Product Portfolio

                               10.7.4.   Recent Development and Strategies Adopted

                               10.7.5.   SWOT Analysis

                     10.8 DulcoEase

                               10.8.1.   Business Overview

                               10.8.2.   Active Pharmaceutical Ingredients Analysis

                                              10.8.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.8.3.   Product Portfolio

                               10.8.4.   Recent Development and Strategies Adopted

                               10.8.5.   SWOT Analysis

                     10.9.   Anofer Sun

                               10.9.1.   Business Overview

                               10.9.2.   Active Pharmaceutical Ingredients Analysis

                                              10.9.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.9.3.   Product Portfolio

                               10.9.4.   Recent Development and Strategies Adopted

                               10.9.5.   SWOT Analysis

                     10.10.   Fe-King PN

                               10.10.1.   Business Overview

                               10.10.2.   Active Pharmaceutical Ingredients Analysis

                                              10.10.2.1.   Active Pharmaceutical Ingredients – Existing/Funding

                               10.10.3.   Product Portfolio

                               10.10.4.   Recent Development and Strategies Adopted

                               10.10.5.   SWOT Analysis

Connect to Analyst

Connect to Analyst

Research Methodology

Research Methodology